Skip to main content
SpringerLink
Log in

Dyslipidemia is not associated with interferon-regulated chemokines or disease activity in systemic lupus erythematosus

  • LETTERS OF BIOMEDICAL AND CLINICAL RESEARCH
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Data availability

All data are available on request to the corresponding author.

References

  1. O’Hagan R, Berg AR, Hong CG, Parel PM, Mehta NN, Teague HL (2022) Systemic consequences of abnormal cholesterol handling: interdependent pathways of inflammation and dyslipidemia. Front Immunol 13:972140. https://doi.org/10.3389/fimmu.2022.972140

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Huang S, Zhang Z, Cui Y, Yao G, Ma X, Zhang H (2023) Dyslipidemia is associated with inflammation and organ involvement in systemic lupus erythematosus. Clin Rheumatol. https://doi.org/10.1007/s10067-023-06539-2

  3. Quevedo-Abeledo JC, Martín-González C, Ferrer-Moure C, de Armas-Rillo L, Hernandez-Hernandez MV, González-Gay MÁ, Ferraz-Amaro I (2022) Key molecules of triglycerides pathway metabolism are disturbed in patients with systemic lupus erythematosus. Front Immunol 13:827355. https://doi.org/10.3389/fimmu.2022.827355

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Ghorbaninezhad F, Leone P, Alemohammad H, Najafzadeh B, Nourbakhsh NS, Prete M, Malerba E, Saeedi H, Tabrizi NJ, Racanelli V, Baradaran B (2022) Tumor necrosis factor-α in systemic lupus erythematosus: Structure, function and therapeutic implications (Review). Int J Mol Med 49:43. https://doi.org/10.3892/ijmm.2022.5098

    Article  PubMed  Google Scholar 

  5. Caielli S, Wan Z, Pascual V (2023) Systemic lupus erythematosus pathogenesis: interferon and beyond. Annu Rev Immunol 41:533–560. https://doi.org/10.1146/annurev-immunol-101921-042422

    Article  CAS  PubMed  Google Scholar 

  6. Mora-Arias T, Amezcua-Guerra LM (2020) Type III interferons (Lambda Interferons) in rheumatic autoimmune diseases. Arch Immunol Ther Exp 68:1. https://doi.org/10.1007/s00005-019-00564-3

    Article  CAS  Google Scholar 

  7. Espinosa-Bautista F, Coronel D, Ramos-Rosillo V, Amezcua-Guerra LM (2022) Performance analysis of Luminex and ELISA to profile serum IP-10 as a biomarker in systemic lupus erythematosus. Lupus 31:1660–1665. https://doi.org/10.1177/09612033221122978

    Article  CAS  PubMed  Google Scholar 

  8. Palazzo L, Lindblom J, Mohan C, Parodis I (2022) Current insights on biomarkers in lupus nephritis: a systematic review of the literature. J Clin Med 11:5759. https://doi.org/10.3390/jcm11195759

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Albar Z, Wijaya LK (2006) Is there a relationship between serum C-reactive protein level and dyslipidaemia in systemic lupus erythematosus? Acta Med Indones 38:23–28

    PubMed  Google Scholar 

  10. Liu XR, Qi YY, Zhao YF, Cui Y, Zhao ZZ (2023) Plasma soluble tumor necrosis factor receptor I as a biomarker of lupus nephritis and disease activity in systemic lupus erythematosus patients. Ren Fail 45:2174355. https://doi.org/10.1080/0886022X.2023.2174355

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Funding

This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.

Author information

Authors and Affiliations

  1. School of Medicine, Universidad Autónoma Metropolitana–Xochimilco, Mexico City, Mexico

    Leonardo Hernández-Solano

  2. National Preparatory High School Antonio Caso, Universidad Nacional Autónoma de México, Mexico City, Mexico

    Emanuel Amezcua-Castillo

  3. Department of Immunology, Instituto Nacional de Cardiología Ignacio Chávez, Mexico City, Mexico

    Luis M. Amezcua-Guerra

  4. Health Care Department, Universidad Autónoma Metropolitana–Xochimilco, Mexico City, Mexico

    Luis M. Amezcua-Guerra

Authors
  1. Leonardo Hernández-Solano
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Emanuel Amezcua-Castillo
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Luis M. Amezcua-Guerra
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

All authors contributed to the study’s conception and design. Material preparation and data collection were performed by Leonardo Hernández-Solano and Emanuel Amezcua-Castillo. Statistical analysis was performed by Leonardo Hernández-Solano and Luis M Amezcua-Guerra. The first draft of the manuscript was written by Luis M Amezcua-Guerra and all authors commented on previous versions of the manuscript. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Luis M. Amezcua-Guerra.

Ethics declarations

Ethical approval

Protocol number 16–960, Comité de Ética del Instituto Nacional de Cardiología Ignacio Chávez. Patients consented to participate, authorizing the use of clinical and laboratory data for research purposes.

Human rights

All procedures followed the 2013 Declaration of Helsinki and local regulations.

Competing interests

The authors have no relevant financial or non-financial interests to disclose.

Additional information

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Hernández-Solano, L., Amezcua-Castillo, E. & Amezcua-Guerra, L.M. Dyslipidemia is not associated with interferon-regulated chemokines or disease activity in systemic lupus erythematosus. Clin Rheumatol 42, 1993–1995 (2023). https://doi.org/10.1007/s10067-023-06631-7

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10067-023-06631-7

Search

Navigation